A carregar...
Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
Inhibition of proteasome, a proteolytic complex responsible for the degradation of ubiquitinated proteins, has emerged as a powerful strategy for treatment of multiple myeloma (MM), a plasma cell malignancy. First-in-class agent, bortezomib, has demonstrated great positive therapeutic efficacy in MM...
Na minha lista:
Publicado no: | J Cell Mol Med |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley & Sons, Ltd
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4508135/ https://ncbi.nlm.nih.gov/pubmed/24712303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12279 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|